ADHD Therapeutics Market was valued at US$ 28,594.55 Billion in 2022 and is expected to reach US$ 64,742.37 Billion by 2030; it is estimated to record a CAGR of 10.8% from 2022 to 2030 Pharmaceuticals ADHD Therapeutics Market was valued at US$ 28,594.55 Billion in 2022 and is expected to reach US$ 64,742.37 Billion by 2030; it is estimated to record a CAGR of 10.8% from 2022 to 2030 Market News Insights August 26, 2024 North America held the largest share of the global ADHD therapeutics market in 2022. In the region,... Read More Read more about ADHD Therapeutics Market was valued at US$ 28,594.55 Billion in 2022 and is expected to reach US$ 64,742.37 Billion by 2030; it is estimated to record a CAGR of 10.8% from 2022 to 2030
